EMEA-000917-PIP01-10-M04
Key facts
| Invented name |
|
| Active substance |
bimatoprost
|
| Therapeutic area |
Dermatology
|
| Decision number |
P/0293/2014
|
| PIP number |
EMEA-000917-PIP01-10-M04
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
|
| Contact for public enquiries |
Allergan Pharmaceuticals International Limited
E-mail: ml-eu_reg_affairs@allergan.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|